1
Nov
2022

Shilpa Medicare Ltd.

Exhibitor at CPHI Frankfurt 2022 stand 120D62, API
About Us

We are dealing with high-quality Active Pharmaceutical Ingredients (APIs), Formulations, New Drug Delivery Systems and Specialty Chemicals utilising sophisticated technology meticulously in order to comply with international standards/specifications. Today we are among the world's leading suppliers of Oncology/non- Oncology APIs, intermediates and Formulations. Shilpa Medicare's facilities have received key regulatory approvals for its facilities as well as for the products from USFDA, EUGMP, TGA, PMDA, Cofepris, Anvisa and KFDA with diverse regulatory recognized manufacturing set ups and excellent scientific manpower. We are ISO 14001: 2004 certified organization and committed to implement, maintain and improve the environmental management system so as to assure its conformity with our stated environmental policy. We offer a broad and integrated portfolio of products and services (CRAMS) to the global pharmaceutical industry. Being proactive in approach, we continuously seek out avenues and first available opportunities for development of new products drawing strength from our zeal to provide affordable healthcare to everyone. Our state-of-the-art infrastructure, more than 2 decades of experience, and rigorous across-the-board quality standards all contribute to our commitment- Quality Healthcare at a price which everyone can afford. Being Shilpa Medicare companies, our vision and business plans are shared by our subsidiary organizations: We are known as a successful and reliable partner within the pharmaceutical domain. Buyers within the country and from across the borders count on our fast track integrated development plans. Shilpa Medicare's skilled team and certified manufacturing capabilities have proved to be significant differentiator among discerning buyers in the highly regulated markets of US and Europe. Besides exporting to USA, Canada, Australia, Japan and European Countries viz.,Germany, Switzerland, Netherlands, Belgium, Spain, Greece, Cyprus, Italy, United Kingdom etc., we also cater to South American Countries like Mexico, Brazil, and Columbia etc.; African Countries like Kenya, Nigeria and West Indies etc. and Asian Countries like Singapore, Taiwan, China, Malaysia, Thailand, etc. At Shilpa Medicare, we make every effort to create an environment of openness and transparency. We believe in maintaining the trust and respect of all of our stakeholders and customers by acting with integrity at all times. Our ultimate goal is to help all levels of society in living healthier lives.

  • IN
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
Contact info
Event information
CPHI Frankfurt 2022
  • 1-3 November 2022
  • Messe Frankfurt, Germany
  • Visit us at stand 120D62, API

Products Featured at CPHI Frankfurt 2022

  • Azacitidine

    Product Azacitidine

    Shilpa Medicare Ltd. offers a wide range of products including Azacitidine. It is a type of oncology API’s. Tech pack: Available. Contact us for more information.
  • Cabazitaxel Amorphous

    Product Cabazitaxel Amorphous

    Shilpa Medicare Ltd. offers a wide range of products including Cabazitaxel amorphous. It is a type of oncology API’s. Tech pack: Available. Contact us for more information.
  • Regorafenib

    Product Regorafenib

    Its a Oncology API
  • Enzalutamide

    Product Enzalutamide

    Its a Oncology API